Attorney General Mills announces settlement with maker of EpiPen for overbilling taxpayers
AUGUSTA ? Attorney General Janet T. Mills announced today that Maine has agreed in principle to join the United States and other States to settle allegations against Mylan Inc. and its wholly-owned subsidiary, Mylan Specialty L.P. (collectively ?Mylan?). The settlement will resolve allegations that Mylan knowingly underpaid rebates owed to the Medicaid program for the drugs EpiPen? and EpiPen Jr.? (?EpiPen?) dispensed to Medicaid beneficiaries. Under the settlement, Mylan will pay $465 million to the United States and the States. The States will share $213,936,000 of the total settlement.